Duliege Anne-Marie

Rigel Pharmaceuticals, Inc.

EVP & Chief Medical Officer

Avg. Two Year Performance

No Purchase Track Record

29% Avg. Sale Return 14% Compound

Holdings: 0 shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions